Brain, Vol. 113, No. 5, 1269-1289, 1990
© 1990 Guarantors of Brain
research-article |
A STUDY OF IMMUNOGLOBULIN G IN THE CEREBROSPINAL FLUID OF 1007 PATIENTS WITH SUSPECTED NEUROLOGICAL DISEASE USING ISOELECTRIC FOCUSING AND THE LOG IgG-INDEX
A COMPARISON AND DIAGNOSTIC APPLICATIONS
Institute of Neurology, Queen Square London, UK
Correspondence to:
Correspondence to: Dr E. J. Thompson, Institute of Neurology, Queen Square, London WC1N 3BG, UK.
Cerebrospinal fluid and serum immunoglobulin G from 1007 patients with suspected neurological disease were analysed by 2 methods: isoelectric focusing for the detection of oligoclonal banding, and quantitative measurement of IgG and albumin for the formulation of a Log IgG-Index. A comparison of the 2 methods in the detection of local synthesis of IgG showed that isoelectric focusing not only gave a much higher yield overall, with 282 patients showing local synthesis versus 225 for the Log IgG-Index, but also a higher specificity, with a false positive rate of 0% versus 3.5%. In addition, of the 282 patients positive by isoelectric focusing only 163 (58%) were positive by the Log IgG-Index.
Of the 1007 patients studied, 206 had multiple sclerosis (MS), and isoelectric focusing showed local synthesis in 95% of clinically definite cases, with a 90% detection rate overall. The Log IgG-Index was positive in only 67% of clinically definite cases, with an overall 59% detection rate. Thus with the exceptions noted above, local synthesis of IgG as defined by isoelectric focusing is confined to demyelinating, inflammatory, infectious and postinfectious disorders.
Our results compare very favourably with the published sensitivities of magnetic resonance imaging in the detection of abnormalities in multiple sclerosis, and better than those for evoked potentials. Where both these investigations are readily available isoelectric focusing provides a useful adjunct. For the majority of physicians and neurologists who do not have ready access to magnetic resonance imaging, isoelectric focusing is an excellent alternative. We would also recommend that it become the standard for the measurement of IgG abnormalities in the cerebrospinal fluid and that the use of quantitative data be abandoned for routine purposes.
Received May 24, 1989. Revised September 8, 1989. Accepted September 22, 1989.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M Podbielska and E. Hogan Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis? Multiple Sclerosis, September 1, 2009; 15(9): 1011 - 1029. [Abstract] [PDF] |
||||
![]() |
A Theodoridou and L Settas Demyelination in rheumatic diseases Postgrad. Med. J., March 1, 2008; 84(989): 127 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yin Mok, E. Y T Chan, W. Sing Wong, and C. Sing Lau Intrathecal immunoglobulin production in patients with systemic lupus erythematosus with neuropsychiatric manifestations Ann Rheum Dis, June 1, 2007; 66(6): 846 - 847. [Full Text] [PDF] |
||||
![]() |
A Theodoridou and L Settas Demyelination in rheumatic diseases. J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 290 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Freedman, E. J. Thompson, F. Deisenhammer, G. Giovannoni, G. Grimsley, G. Keir, S. Ohman, M. K. Racke, M. Sharief, C. J. M. Sindic, et al. Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis: A Consensus Statement Arch Neurol, June 1, 2005; 62(6): 865 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Villar, J. Masjuan, M. C. Sadaba, P. Gonzalez-Porque, J. Plaza, A. Bootello, and J. C. Alvarez-Cermeno Early Differential Diagnosis of Multiple Sclerosis Using a New Oligoclonal Band Test Arch Neurol, April 1, 2005; 62(4): 574 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S Freedman Primary progressive multiple sclerosis: cerebrospinal fluid considerations Multiple Sclerosis, June 1, 2004; 10(1_suppl): S31 - S35. [Abstract] [PDF] |
||||
![]() |
M. S Freedman Primary progressive multiple sclerosis: cerebrospinal fluid considerations Multiple Sclerosis, May 1, 2004; 10(3_suppl): S31 - S35. [Abstract] [PDF] |
||||
![]() |
R Bergamaschi, S Tonietti, D Franciotta, E Candeloro, E Tavazzi, G Piccolo, A Romani, and V Cosi Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations Multiple Sclerosis, February 1, 2004; 10(1): 2 - 4. [Abstract] [PDF] |
||||
![]() |
J de Seze, C Lebrun, T Stojkovic, D Ferriby, M Chatel, and P Vermersch Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis Multiple Sclerosis, October 1, 2003; 9(5): 521 - 525. [Abstract] [PDF] |
||||
![]() |
G. Davies, G. Keir, E. J. Thompson, and G. Giovannoni The clinical significance of an intrathecal monoclonal immunoglobulin band: A follow-up study Neurology, April 8, 2003; 60(7): 1163 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Verbeek, H. P.M. de Reus, and C. W. Weykamp Comparison of Methods for the Detection of Oligoclonal IgG Bands in Cerebrospinal Fluid and Serum: Results of the Dutch Quality Control Survey Clin. Chem., September 1, 2002; 48(9): 1578 - 1580. [Full Text] [PDF] |
||||
![]() |
S. Richard, V. Miossec, J.-F. Moreau, and J.-L. Taupin Detection of Oligoclonal Immunoglobulins in Cerebrospinal Fluid by an Immunofixation-Peroxidase Method Clin. Chem., January 1, 2002; 48(1): 167 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Malcus-Vocanson, P Giraud, F Micoud, V Janin, M H Charles, E Broussolle, G Chazot, B Mandrand, and H Perron Glial toxicity in urine and multiple sclerosis Multiple Sclerosis, December 1, 2001; 7(6): 383 - 388. [Abstract] [PDF] |
||||
![]() |
J Palace MAKING THE DIAGNOSIS OF MULTIPLE SCLEROSIS J. Neurol. Neurosurg. Psychiatry, December 1, 2001; 71(suppl_2): ii3 - ii8. [Full Text] [PDF] |
||||
![]() |
J. H. Rees, S. F. Hain, M. R. Johnson, R. A. C. Hughes, D. C. Costa, P. J. Ell, G. Keir, and P. Rudge The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders Brain, November 1, 2001; 124(11): 2223 - 2231. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Colombo, M. Dono, P. Gazzola, S. Roncella, A. Valetto, N. Chiorazzi, G. L. Mancardi, and M. Ferrarini Accumulation of Clonally Related B Lymphocytes in the Cerebrospinal Fluid of Multiple Sclerosis Patients J. Immunol., March 1, 2000; 164(5): 2782 - 2789. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Reindl, C. Linington, U. Brehm, R. Egg, E. Dilitz, F. Deisenhammer, W. Poewe, and T. Berger Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study Brain, November 1, 1999; 122(11): 2047 - 2056. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kidd, A Steuer, A. M. Denman, and P. Rudge Neurological complications in Behcet's syndrome Brain, November 1, 1999; 122(11): 2183 - 2194. [Abstract] [Full Text] [PDF] |
||||








